Menu Search
Equities

Accelerate Diagnostics Inc

0H8E:LSE

Accelerate Diagnostics Inc

Actions
  • Price (USD)1.54
  • Today's Change1.54 / --
  • Shares traded982.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Sep 09 2024 16:34 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Accelerate Diagnostics Inc has grown net income from a loss of -62.49m to a smaller loss of -61.62m despite declining revenues.
Gross margin27.16%
Net profit margin-309.87%
Operating margin-354.35%
Return on assets-104.22%
Return on equity--
Return on investment-1,349.93%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Accelerate Diagnostics Inc fell by 22.77m. Cash Flow from Financing totalled 9.02m or 74.79% of revenues. In addition the company used 40.20m for operations while cash from investing totalled 8.66m.
Cash flow per share-1.93
Price/Cash flow per share--
Book value per share-1.47
Tangible book value per share-1.47
More ▼

Balance sheet in USDView more

Accelerate Diagnostics Inc appears to have a weak balance sheet, highlighted by its negative owner's equity.
Current ratio1.28
Quick ratio1.04
Total debt/total equity--
Total debt/total capital6.38
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.